Sunshine Biopharma (SBFM) EBT Margin Growth (1y) (2019 - 2026)
Sunshine Biopharma (SBFM) EBT Margin Growth (1y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | -1,585.00 |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | -177.00 |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -27.00 |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | -356.00 |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 436.00 |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | -629.00 |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 208.00 |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Sunshine Biopharma | 1.58 Mn | -12.17 Mn | 2.43 Mn | 416.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 416.00 |
| Mar 31, 2026 | -167.00 |
| Dec 31, 2025 | 364.00 |
| Sep 30, 2025 | 80.00 |
| Jun 30, 2025 | -1,203.00 |
| Mar 31, 2025 | 302.00 |
| Dec 31, 2024 | -1,043.00 |
| Sep 30, 2024 | -140.00 |
| Jun 30, 2024 | 564.00 |
| Mar 31, 2024 | 1,711.00 |
| Dec 31, 2023 | 57,745.00 |
| Sep 30, 2023 | 108,684.00 |
| Jun 30, 2023 | 34,387.00 |
| Mar 31, 2023 | 97,414.00 |
| Dec 31, 2022 | -137,462.00 |
| Sep 30, 2022 | 692,138.00 |
| Jun 30, 2022 | 508,661.00 |
| Mar 31, 2022 | 1.44 Mn |
| Dec 31, 2021 | 465,265.00 |
| Sep 30, 2021 | -394,503.00 |